- Home
- USIO vs CLNN Comparison
USIO vs CLNN Comparison
Compare USIO & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | USIO | CLNN |
|---|---|---|
| Founded | 1998 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 58.8M | 67.5M |
| IPO Year | 1999 | 2021 |
Fundamental Metrics
Financial Performance| Metric | USIO | CLNN |
|---|---|---|
| Price | $2.71 | $4.49 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $4.00 | ★ $33.75 |
| AVG Volume (30 Days) | ★ 475.7K | 77.4K |
| Earning Date | 05-13-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $28,200,535.00 | $200,000.00 |
| Revenue This Year | $12.15 | $17.64 |
| Revenue Next Year | $8.57 | $19,516.77 |
| P/E Ratio | $291.00 | ★ N/A |
| Revenue Growth | ★ 12.69 | N/A |
| 52 Week Low | $1.03 | $3.88 |
| 52 Week High | $3.05 | $13.50 |
Technical Indicators
Market Signals| Indicator | USIO | CLNN |
|---|---|---|
| Relative Strength Index (RSI) | 58.98 | 42.08 |
| Support Level | $1.28 | $3.92 |
| Resistance Level | $2.98 | $4.60 |
| Average True Range (ATR) | 0.25 | 0.42 |
| MACD | 0.03 | 0.06 |
| Stochastic Oscillator | 61.86 | 37.63 |
Price Performance
Historical ComparisonAbout USIO Usio Inc.
Usio Inc is a cloud-based Fintech payment processor. The company serves multiple industry verticals with technology that facilitates payment acceptance and funds disbursement in a single, full-stack ecosystem. It provides payment acceptance through multiple payment methods, including payment facilitation, prepaid card, and electronic billing products and services to businesses, merchants, and consumers. The company's reportable operating segments are Output Solutions and Merchant Services, and these segments.
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.